Microplastics in Penile Tissue: What Two Studies Show

Microplastics in penile tissue have been reported in small surgical studies, but detection does not establish what caused a patient’s illness.

A useful way to read the research is to separate three questions: whose tissue was sampled, what the instrument measured, and which health outcome was actually tested.

Image context: The featured torso and microscope-slide scene is a conceptual illustration, not a patient image, study micrograph, anatomical map of particle deposits, or representation of particle size.

Two studies examined different clinical groups

The headline about a tiny prosthesis-surgery series should not be combined with a later cancer-tissue paper as though both sampled the same population.

In the second design, adjacent tissue provides a local comparison within a person. It does not represent a separate person without cancer or show what the tissue looked like before the disease developed.

What does the 80% finding count?

The 2024 abstract reports detection in 80% of samples; CNN’s contemporaneous report describes four positive main samples from five men. That percentage is not an estimate for all men.

Its infrared analysis detected particles measuring 20 to 500 micrometers, while electron microscopy detected smaller particles down to about 2 micrometers. PET at 47.8% and polypropylene at 34.7% describe identified particles, not percentages of patients.

The 2025 abstract reports detection in 85.3% of samples and an average abundance of 6.42 particles per gram. It reports greater abundance and diversity in cancerous than adjacent tissue, but its abstract does not provide a prospective cancer-risk estimate.

The units answer different questions, so they need separate labels. A percentage of positive samples cannot be read as a percentage chance of developing a disease, and a particle count is not a diagnosis.

What can a control actually control?

A laboratory control and a clinical comparison group have different jobs. The word alone is not enough to tell you which conclusion a study can support.

A container control can help examine a collection or storage issue. It cannot answer the separate question of whether people with a disease have a different exposure history from otherwise comparable people without it.

Likewise, comparing two tissue regions can help identify a local difference without establishing why that difference exists. A credible causal explanation still needs evidence about timing and competing explanations.

When reading a report, complete this sentence: The comparison was between ___ and ___. If the headline makes a claim about a different comparison, pause before accepting that extra step.

The instrument sets the measurement boundary

The smallest particle reported is not automatically the smallest particle present. A useful methods description explains the detection range, how plastic was identified, and how collection and processing contamination were assessed.

The FDA identifies major gaps in standardized definitions, sample preparation, quality controls and detection methods. It cautions that inconsistent analytical methods make studies difficult to compare and limit health-risk assessment.

Before comparing two numbers, check whether both studies counted the same sizes and polymer types with comparable sampling rules. An unreported size category should not be filled in with a guess, and measurements from different tissue settings should not be averaged into one headline.

Does this prove a cause of erectile dysfunction or cancer?

No causal conclusion follows from finding a material after someone already has a condition. A tissue result can motivate further research while leaving the direction, timing and clinical importance of a relationship unresolved.

The stronger question is not simply whether a later study finds more particles. It is whether an appropriate design can connect exposure, subsequent health outcomes and alternative explanations.

Evidence of a possible biological mechanism also answers a different question from a human clinical outcome. Avoid treating a proposed pathway as though it supplies the missing comparison or proves a benefit from removing an exposure.

A four-line card for the next headline

Copy these four labels when a new tissue study appears. This is a reading aid, not a medical score or a test for your own exposure.

1. People: Write the clinical group and recruitment setting, rather than the broad word men.
2. Comparison: Name the actual comparator, including whether it was another tissue region, a collection control, or another group of people.
3. Measurement: Record the unit and denominator before the headline percentage.
4. Unanswered decision: State which health claim or proposed action would require a different study.

The card is useful even when a complete paper is unavailable. Mark a detail not reported rather than borrowing it from another article or assuming that two similar study titles describe identical methods.

What should readers take from the evidence?

The FDA says current evidence does not demonstrate that the levels detected in foods pose a human-health risk, while substantial gaps remain. That food-specific statement is not a clearance of every tissue finding or proof that all possible exposures are harmless.

A household product choice and a medical outcome require their own evidence. Neither a dramatic tissue headline nor a product’s detox wording establishes that buying something will improve sexual function or prevent cancer.

If you have sexual-health concerns, discuss them with a qualified clinician rather than using a research detection percentage as a self-test. Bring the actual article or product claim if it is influencing a care decision.

The useful conclusion is specific: keep the study’s population, comparator and measurement attached to its result. That preserves the finding without turning a small observational report into a personal diagnosis or a guaranteed fix.

Sources

Codrington, J., and colleagues. (2025; online 2024). Detection of microplastics in the human penis. International Journal of Impotence Research, 37, 377 to 383. doi:10.1038/s41443-024-00930-6.

Guy, J. (2024, June 19). Microplastics discovered in human penises for the first time. CNN.

Wang, M., and colleagues. (2025). Identification and analysis of microplastics in human penile cancer tissues. Science of the Total Environment, 969, 178815. doi:10.1016/j.scitotenv.2025.178815.

U.S. Food and Drug Administration. Microplastics and nanoplastics in foods. Accessed October 28, 2026.